# US 2025/0093345 A1 · Optical biomodule for detection of diseases at an early onset

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0093345 A1
- Document ID: US20250093345A1
- Status: Published application
- Kind: A1
- Application number: 18/831,208
- Filed: 2024-09-14
- Published: 2025-03-20
- Earliest claimed: 2019-09-28
- Inventors: Mohammad A. Mazed
- Web page: https://patentgrep.com/patent/US20250093345A1

## CPC

- G01N 33/5436: {with ligand physically entrapped within the solid phase (liposomes G01N33/5432; immunological test elements G01N33/54386)}
- G01N 21/03: Cuvette constructions
- G01N 21/6428: {Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53)}
- G01N 33/54386: {Analytical elements}
- A61M 35/10: {Wearable devices, e.g. garments, glasses or masks}
- A61M 37/0015: {by using microneedles}
- A61M 2037/0023: {Drug applicators using microneedles}
- G01N 2021/6441: {with two or more labels}
- G01N 21/65: Raman scattering
- G01N 2201/06113: Coherent sources; lasers
- G01N 2458/15: Non-radioactive isotope labels, e.g. for detection by mass spectrometry
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

An optical biomodule for detecting a disease specific biomarker(s) at an early stage, utilizing enhanced fluorescence emission (due to integration of three-dimensional (3-D) structures in a fluidic container) upon chemical binding/coupling of a disease specific biomarker(s) with its corresponding disease specific biomarker binder(s)-coupled with a fluorophore(s) positioned horizontally within a geometrical area (that includes a center region or a middle region) is disclosed. Furthermore, a corresponding disease specific biomarker binder(s) may include an amplifying chemical structure/sequence. The three-dimensional (3-D) structure(s) may be coupled with an optical resonator and/or a photonic crystal (PC) and/or a metamaterial and/or a metamaterial of Epsilon-Near-Zero (ENZ) of a suitable wavelength range.

## Claims

### Claim 1

An optical biomodule comprising:
(a) a fluidic container;
wherein the fluidic container comprises one or more (i) materials or (ii) first metamaterials,
wherein the fluidic container further comprises a first biomarker binder and/or a second biomarker binder,
wherein the first biomarker binder comprises one or more segments,
wherein the second biomarker binder comprises one or more segments,
wherein the first biomarker binder is coupled with one or more first fluorophores,
wherein the second biomarker binder is coupled with one or more second fluorophores,
wherein the first biomarker binder binds or couples with a biomarker,
wherein the second biomarker binder binds or couples with the biomarker,
wherein the fluidic container further comprises a plurality of three-dimensional (3-D) structures,
wherein the three-dimensional (3-D) structures are spaced or arranged in a one-dimensional (1-D) array or in a two-dimensional (2-D) array,
wherein a pitch or a duty cycle of the one-dimensional (1-D) array or the two-dimensional (2-D) array of the three-dimensional (3-D) structures is varied for an enhancement of a fluorescence emission or a light signal,
wherein at least (i) one of the one or more first fluorophores or (ii) one of the one or more second fluorophores is within a geometrical area in a horizontal plane, wherein the geometrical area in the horizontal plane includes a center region or a middle region in the horizontal plane, wherein the center region or the middle region in the horizontal plane is within a gap in the horizontal plane, wherein the geometrical area in the horizontal plane is defined by at least the gap in the horizontal plane, wherein the gap in the horizontal plane is defined by at least one of the one or more three-dimensional (3-D) structures,
(b) a light source for inducing the fluorescence emission or the light signal; and
(c) a device for detecting the fluorescence emission or the light signal, wherein the device comprises (i) a photodiode or (ii) a light sensor.

### Claim 2 (depends on 1)

The optical biomodule according to claim 1, wherein the fluidic container further comprises a substrate or a well or an optical waveguide.

### Claim 3 (depends on 1)

The optical biomodule according to claim 1, wherein the fluidic container (i) further comprises periodic layers of the one or more materials or (ii) coupled with a microfluidic chip, wherein the microfluidic chip comprises one or more microfluidic channels.

### Claim 4 (depends on 1)

The optical biomodule according to claim 1, wherein the first biomarker binder or the second biomarker binder comprises (i) an amplifier that includes nucleotides or (ii) a chemical structure that is coupled with a metal and/or a dielectric material, wherein the amplifier is a linear amplifier or a nonlinear amplifier.

### Claim 5 (depends on 1)

The optical biomodule according to claim 1, wherein at least one of the three-dimensional (3-D) structures is coupled with (i) a photonic crystal (PC) or (ii) a second metamaterial, wherein the second metamaterial is an Epsilon-Near-Zero (ENZ).

### Claim 6 (depends on 1)

The optical biomodule according to claim 1, wherein at least one of the three-dimensional (3-D) structures is coupled with a third metamaterial, wherein the third metamaterial is a hyperbolic metamaterial (HMM).

### Claim 7 (depends on 6)

The optical biomodule according to claim 6, wherein the third metamaterial is coupled with one or more nanoscaled holes or gratings.

### Claim 8 (depends on 1)

The optical biomodule according to claim 1, wherein at least one of the three-dimensional (3-D) structures is coupled with an optical resonator.

### Claim 9 (depends on 1)

The optical biomodule according to claim 1, wherein at least one of the three-dimensional (3-D) structures is within a recessed closed cavity or within a recessed open cavity.

### Claim 10 (depends on 1)

The optical biomodule according to claim 1, wherein at least one of the three-dimensional (3-D) structures is on a substrate or within a well or within an optical waveguide.

### Claim 11 (depends on 1)

The optical biomodule according to claim 1, wherein at least one of the three-dimensional (3-D) structures is coupled or integrated with the light source, wherein the light source comprises a nanoscaled light source or quantum-entangled photons, wherein a maximum dimension of the nanoscaled light source is less than 1000 nanometers.

### Claim 12 (depends on 1)

The optical biomodule according to claim 1, wherein the light source is selected from the group consisting of a quantum dot laser, a squeezed light laser, a light source based on a two-dimensional material, a chip-scaled titanium:sapphire-on-insulator waveguide laser and a Bose-Einstein condensate (BEC) coupled light source, wherein the chip-scaled titanium:sapphire-on-insulator waveguide laser is optically pumped.

### Claim 13 (depends on 1)

The optical biomodule according to claim 1, wherein the light sources comprise a first coherent light source and a second coherent light source, wherein a light beam of the first coherent light source has an open toroidal shape in cross-section, wherein the first coherent light source and the second coherent light source are activated simultaneously.

### Claim 14 (depends on 1)

The optical biomodule according to claim 1, wherein the biomarker or the first biomarker binder or the second biomarker binder is trapped by a trap, wherein the trap comprises (i) one or more nanoscaled focusing elements or one or more nanoscaled holes and (ii) a laser.

### Claim 15 (depends on 1)

The optical biomodule according to claim 1, further comprises a spectrophotometer for detecting a Raman signal.

### Claim 16 (depends on 15)

The optical biomodule according to claim 15, wherein the spectrophotometer is coupled with (i) a refractive optical element and/or (ii) a reflective optical element and/or (iii) a light concentrator.

### Claim 17 (depends on 15)

The optical biomodule according to claim 15, wherein the spectrophotometer is communicatively interfaced with a set of computer implemented instructions in artificial intelligence or an artificial neural network (ANN), wherein the set of computer implemented instructions is stored in one or more non-transitory storage media.

### Claim 18

An optical biomodule comprising:
(a) a fluidic container;
wherein the fluidic container comprises one or more (i) materials or (ii) first metamaterials,
wherein the fluidic container further comprises a first biomarker binder and/or a second biomarker binder,
wherein the first biomarker binder comprises one or more segments,
wherein the second biomarker binder comprises one or more segments,
wherein the first biomarker binder is coupled with one or more first fluorophores,
wherein the second biomarker binder is coupled with one or more second fluorophores,
wherein the first biomarker binder binds or couples with a biomarker,
wherein the second biomarker binder binds or couples with the biomarker,
wherein the first biomarker binder or the second biomarker binder comprises (i) an amplifier that includes nucleotides or (ii) a chemical structure that is coupled with a metal and/or a dielectric material, wherein the amplifier is a linear amplifier or a nonlinear amplifier,
wherein the fluidic container further comprises a plurality of three-dimensional (3-D) structures,
wherein the three-dimensional (3-D) structures are spaced or arranged in a one-dimensional (1-D) array or in a two-dimensional (2-D) array,
wherein a pitch or a duty cycle of the one-dimensional (1-D) array or the two-dimensional (2-D) array of the three-dimensional (3-D) structures is varied for an enhancement of a fluorescence emission or a light signal,
wherein at least (i) one of the one or more first fluorophores or (ii) one of the one or more second fluorophores is within a geometrical area in a horizontal plane, wherein the geometrical area in the horizontal plane includes a center region or a middle region in the horizontal plane, wherein the center region or the middle region in the horizontal plane is within a gap in the horizontal plane, wherein the geometrical area in the horizontal plane is defined by at least the gap in the horizontal plane, wherein the gap in the horizontal plane is defined by at least one of the one or more three-dimensional (3-D) structures,
(b) a light source for inducing the fluorescence emission or the light signal; and
(c) a device for detecting the fluorescence emission or the light signal, wherein the device comprises (i) a photodiode or (ii) a light sensor.

### Claim 19 (depends on 18)

The optical biomodule according to claim 18, wherein the fluidic container further comprises a substrate or a well or an optical waveguide.

### Claim 20 (depends on 18)

The optical biomodule according to claim 18, wherein the fluidic container (i) further comprises periodic layers of the one or more materials or (ii) coupled with a microfluidic chip, wherein the microfluidic chip comprises one or more microfluidic channels.

### Claim 21 (depends on 18)

The optical biomodule according to claim 18, wherein at least one of the three-dimensional (3-D) structures is coupled with (i) a photonic crystal (PC) or (ii) a second metamaterial, wherein the second metamaterial is an Epsilon-Near-Zero (ENZ).

### Claim 22 (depends on 18)

The optical biomodule according to claim 18, wherein at least one of the three-dimensional (3-D) structures is coupled with a third metamaterial, wherein the third metamaterial is a hyperbolic metamaterial (HMM).

### Claim 23 (depends on 22)

The optical biomodule according to claim 22, wherein the third metamaterial is coupled with one or more nanoscaled holes or gratings.

### Claim 24 (depends on 18)

The optical biomodule according to claim 18, wherein at least one of the three-dimensional (3-D) structures is coupled with an optical resonator.

### Claim 25 (depends on 18)

The optical biomodule according to claim 18, wherein at least one of the three-dimensional (3-D) structures is within a recessed closed cavity or within a recessed open cavity.

### Claim 26 (depends on 18)

The optical biomodule according to claim 18, wherein at least one of the three-dimensional (3-D) structures is on a substrate or within a well or within an optical waveguide.

### Claim 27 (depends on 18)

The optical biomodule according to claim 18, wherein at least one of the three-dimensional (3-D) structures is coupled or integrated with the light source, wherein the light source comprises a nanoscaled light source or quantum-entangled photons, wherein a maximum dimension of the nanoscaled light source is less than 1000 nanometers.

### Claim 28 (depends on 18)

The optical biomodule according to claim 18, wherein the biomarker or the first biomarker binder or the second biomarker binder is trapped by a trap, wherein the trap comprises (i) one or more nanoscaled focusing elements or one or more nanoscaled holes and (ii) a laser.

### Claim 29 (depends on 18)

The optical biomodule according to claim 18, further comprises a spectrophotometer for detecting a Raman signal.

### Claim 30 (depends on 29)

The optical biomodule according to claim 29, wherein the spectrophotometer is coupled with (i) a refractive optical element and/or (ii) a reflective optical element and/or (iii) a light concentrator.

### Claim 31 (depends on 29)

The optical biomodule according to claim 29, wherein the spectrophotometer is communicatively interfaced with a set of computer implemented instructions in artificial intelligence or an artificial neural network (ANN), wherein the set of computer implemented instructions is stored in one or more non-transitory storage media.

### Claim 32

An optical biomodule comprising:
(a) a fluidic container;
wherein the fluidic container comprises one or more (i) materials or (ii) first metamaterials,
wherein the fluidic container further comprises a first biomarker binder and/or a second biomarker binder,
wherein the first biomarker binder comprises one or more segments,
wherein the second biomarker binder comprises one or more segments,
wherein the first biomarker binder is coupled with one or more first fluorophores,
wherein the second biomarker binder is coupled with one or more second fluorophores,
wherein the first biomarker binder binds or couples with a biomarker,
wherein the second biomarker binder binds or couples with the biomarker,
wherein the fluidic container further comprises a plurality of three-dimensional (3-D) structures,
wherein the three-dimensional (3-D) structures are spaced or arranged in a one-dimensional (1-D) array or in a two-dimensional (2-D) array,
wherein a pitch or a duty cycle of the one-dimensional (1-D) array or the two-dimensional (2-D) array of the three-dimensional (3-D) structures is varied for an enhancement of a fluorescence emission or a light signal,
wherein at least (i) one of the one or more first fluorophores or (ii) one of the one or more second fluorophores is within a geometrical area in a horizontal plane, wherein the geometrical area in the horizontal plane includes a center region or a middle region in the horizontal plane, wherein the center region or the middle region in the horizontal plane is within a gap in the horizontal plane, wherein the geometrical area in the horizontal plane is defined by at least the gap in the horizontal plane, wherein the gap in the horizontal plane is defined by at least one of the one or more three-dimensional (3-D) structures,
wherein at least one of the three-dimensional (3-D) structures is coupled with an optical resonator,
(b) a light source or light sources for inducing the fluorescence emission or the light signal; and
(c) a device for detecting the fluorescence emission or the light signal, wherein the device comprises (i) a photodiode or (ii) a light sensor.

### Claim 33 (depends on 32)

The optical biomodule according to claim 32, wherein the fluidic container further comprises a substrate or a well or an optical waveguide.

### Claim 34 (depends on 32)

The optical biomodule according to claim 32, wherein the fluidic container (i) further comprises periodic layers of the one or more materials or (ii) coupled with a microfluidic chip, wherein the microfluidic chip comprises one or more microfluidic channels.

### Claim 35 (depends on 32)

The optical biomodule according to claim 32, wherein the first biomarker binder or the second biomarker binder comprises (i) an amplifier that includes nucleotides or (ii) a chemical structure that is coupled with a metal and/or a dielectric material, wherein the amplifier is a linear amplifier or a nonlinear amplifier.

### Claim 36 (depends on 32)

The optical biomodule according to claim 32, wherein at least one of the three-dimensional (3-D) structures is further coupled with (i) a photonic crystal (PC) or (ii) a second metamaterial, wherein the second metamaterial is an Epsilon-Near-Zero (ENZ).

### Claim 37 (depends on 32)

The optical biomodule according to claim 32, wherein at least one of the three-dimensional (3-D) structures is further coupled with a third metamaterial, wherein the third metamaterial is a hyperbolic metamaterial (HMM).

### Claim 38 (depends on 37)

The optical biomodule according to claim 37, wherein the third metamaterial is coupled with one or more nanoscaled holes or gratings.

### Claim 39 (depends on 32)

The optical biomodule according to claim 32, wherein at least one of the three-dimensional (3-D) structures is within a recessed closed cavity or within a recessed open cavity.

### Claim 40 (depends on 32)

The optical biomodule according to claim 32, wherein at least one of the three-dimensional (3-D) structures is on a substrate or within a well or within an optical waveguide.

### Claim 41 (depends on 32)

The optical biomodule according to claim 32, wherein at least one of the three-dimensional (3-D) structures is coupled or integrated with the light source, wherein the light source comprises a nanoscaled light source or quantum-entangled photons, wherein a maximum dimension of the nanoscaled light source is less than 1000 nanometers.

### Claim 42 (depends on 32)

The optical biomodule according to claim 32, wherein the biomarker or the first biomarker binder or the second biomarker binder is trapped by a trap, wherein the trap comprises (i) one or more nanoscaled focusing elements or one or more nanoscaled holes and (ii) a laser.

### Claim 43

An optical biomodule comprising:
(a) a fluidic container;
wherein the fluidic container comprises one or more (i) materials or (ii) first metamaterials,
wherein the fluidic container further comprises a first biomarker binder and/or a second biomarker binder,
wherein the first biomarker binder comprises one or more segments,
wherein the second biomarker binder comprises one or more segments,
wherein the first biomarker binder is coupled with one or more first fluorophores,
wherein the second biomarker binder is coupled with one or more second fluorophores,
wherein the first biomarker binder binds or couples with a biomarker,
wherein the second biomarker binder binds or couples with the biomarker,
wherein the fluidic container further comprises a plurality of three-dimensional (3-D) structures,
wherein the three-dimensional (3-D) structures are spaced or arranged in a one-dimensional (1-D) array or in a two-dimensional (2-D) array,
wherein a pitch or a duty cycle of the one-dimensional (1-D) array or the two-dimensional (2-D) array of the three-dimensional (3-D) structures is varied for an enhancement of a fluorescence emission or a light signal,
wherein at least (i) one of the one or more first fluorophores or (ii) one of the one or more second fluorophores is within a geometrical area in a horizontal plane, wherein the geometrical area in the horizontal plane includes a center region or a middle region in the horizontal plane, wherein the center region or the middle region in the horizontal plane is within a gap in the horizontal plane, wherein the geometrical area in the horizontal plane is defined by at least the gap in the horizontal plane, wherein the gap in the horizontal plane is defined by at least one of the one or more three-dimensional (3-D) structures,
wherein at least one of the three-dimensional (3-D) structures is coupled with a photonic crystal (PC),
(b) a light source or light sources for inducing the fluorescence emission or the light signal; and
(c) a device for detecting the fluorescence emission or the light signal, wherein the device comprises (i) a photodiode or (ii) a light sensor.

### Claim 44 (depends on 43)

The optical biomodule according to claim 43, wherein the fluidic container further comprises a substrate or a well or an optical waveguide.

### Claim 45 (depends on 43)

The optical biomodule according to claim 43, wherein the fluidic container (i) further comprises periodic layers of the one or more materials or (ii) coupled with a microfluidic chip, wherein the microfluidic chip comprises one or more microfluidic channels.

### Claim 46 (depends on 43)

The optical biomodule according to claim 43, wherein the first biomarker binder or the second biomarker binder comprises (i) an amplifier that includes nucleotides or (ii) a chemical structure that is coupled with a metal and/or a dielectric material, wherein the amplifier is a linear amplifier or a nonlinear amplifier.

### Claim 47 (depends on 43)

The optical biomodule according to claim 43, wherein at least one of the three-dimensional (3-D) structures is further coupled with a second metamaterial, wherein the second metamaterial is an Epsilon-Near-Zero (ENZ).

### Claim 48 (depends on 43)

The optical biomodule according to claim 43, wherein at least one of the three-dimensional (3-D) structures is further coupled with a third metamaterial, wherein the third metamaterial is a hyperbolic metamaterial (HMM).

### Claim 49 (depends on 48)

The optical biomodule according to claim 48, wherein the third metamaterial is coupled with one or more nanoscaled holes or gratings.

### Claim 50 (depends on 43)

The optical biomodule according to claim 43, wherein at least one of the three-dimensional (3-D) structures is further coupled with an optical resonator.

### Claim 51 (depends on 43)

The optical biomodule according to claim 43, wherein at least one of the three-dimensional (3-D) structures is within a recessed closed cavity or within a recessed open cavity.

### Claim 52 (depends on 43)

The optical biomodule according to claim 43, wherein at least one of the three-dimensional (3-D) structures is on a substrate or within a well or within an optical waveguide.

### Claim 53 (depends on 43)

The optical biomodule according to claim 43, wherein at least one of the three-dimensional (3-D) structures is coupled or integrated with the light source, wherein the light source comprises a nanoscaled light source or quantum-entangled photons, wherein a maximum dimension of the nanoscaled light source is less than 1000 nanometers.

### Claim 54 (depends on 43)

The optical biomodule according to claim 43, wherein the biomarker or the first biomarker binder or the second biomarker binder is trapped by a trap, wherein the trap comprises (i) one or more nanoscaled focusing elements or one or more nanoscaled holes and (ii) a laser.

### Claim 55

An optical biomodule comprising:
(a) a fluidic container;
wherein the fluidic container comprises one or more (i) materials or (ii) first metamaterials,
wherein the fluidic container further comprises a first biomarker binder and/or a second biomarker binder,
wherein the first biomarker binder comprises one or more segments,
wherein the second biomarker binder comprises one or more segments,
wherein the first biomarker binder is coupled with one or more first fluorophores,
wherein the second biomarker binder is coupled with one or more second fluorophores,
wherein the first biomarker binder binds or couples with a biomarker,
wherein the second biomarker binder binds or couples with the biomarker,
wherein the fluidic container further comprises a plurality of three-dimensional (3-D) structures,
wherein the three-dimensional (3-D) structures are spaced or arranged in a one-dimensional (1-D) array or in a two-dimensional (2-D) array,
wherein a pitch or a duty cycle of the one-dimensional (1-D) array or the two-dimensional (2-D) array of the three-dimensional (3-D) structures is varied for an enhancement of a fluorescence emission or a light signal,
wherein at least (i) one of the one or more first fluorophores or (ii) one of the one or more second fluorophores is within a geometrical area in a horizontal plane, wherein the geometrical area in the horizontal plane includes a center region or a middle region in the horizontal plane, wherein the center region or the middle region in the horizontal plane is within a gap in the horizontal plane, wherein the geometrical area in the horizontal plane is defined by at least the gap in the horizontal plane, wherein the gap in the horizontal plane is defined by at least one of the one or more three-dimensional (3-D) structures,
wherein at least one of the three-dimensional (3-D) structures is coupled with a second metamaterial, wherein the second metamaterial is a hyperbolic metamaterial (HMM),
(b) a light source for inducing the fluorescence emission or the light signal; and
(c) a device for detecting the fluorescence emission or the light signal, wherein the device comprises (i) a photodiode or (ii) a light sensor.

### Claim 56 (depends on 55)

The optical biomodule according to claim 55, wherein the fluidic container further comprises a substrate or a well or an optical waveguide.

### Claim 57 (depends on 55)

The optical biomodule according to claim 55, wherein the fluidic container (i) further comprises periodic layers of the one or more materials or (ii) coupled with a microfluidic chip, wherein the microfluidic chip comprises one or more microfluidic channels.

### Claim 58 (depends on 55)

The optical biomodule according to claim 55, wherein the first biomarker binder or the second biomarker binder comprises (i) an amplifier that includes nucleotides or (ii) a chemical structure that is coupled with a metal and/or a dielectric material, wherein the amplifier is a linear amplifier or a nonlinear amplifier.

### Claim 59 (depends on 55)

The optical biomodule according to claim 55, wherein the second metamaterial is coupled with one or more nanoscaled holes or gratings.

### Claim 60 (depends on 55)

The optical biomodule according to claim 55, wherein at least one of the three-dimensional (3-D) structures is further coupled with (i) a photonic crystal (PC) or (ii) a third metamaterial, wherein the third metamaterial is an Epsilon-Near-Zero (ENZ).

### Claim 61 (depends on 55)

The optical biomodule according to claim 55, wherein at least one of the three-dimensional (3-D) structures is further coupled with an optical resonator.

### Claim 62 (depends on 55)

The optical biomodule according to claim 55, wherein at least one of the three-dimensional (3-D) structures is within a recessed closed cavity or within a recessed open cavity.

### Claim 63 (depends on 55)

The optical biomodule according to claim 55, wherein at least one of the three-dimensional (3-D) structures is on a substrate or within a well or within an optical waveguide.

### Claim 64 (depends on 55)

The optical biomodule according to claim 55, wherein at least one of the three-dimensional (3-D) structures is coupled or integrated with the light source, wherein the light source comprises a nanoscaled light source or quantum-entangled photons, wherein a maximum dimension of the nanoscaled light source is less than 1000 nanometers.

### Claim 65 (depends on 55)

The optical biomodule according to claim 55, wherein the biomarker or the first biomarker binder or the second biomarker binder is trapped by a trap, wherein the trap comprises (i) one or more nanoscaled focusing elements or one or more nanoscaled holes and (ii) a laser.

### Claim 66

An optical biomodule comprising:
(a) a fluidic container;
wherein the fluidic container comprises one or more (i) materials or (ii) first metamaterials,
wherein the fluidic container further comprises a first biomarker binder and/or a second biomarker binder,
wherein the first biomarker binder comprises one or more segments,
wherein the second biomarker binder comprises one or more segments,
wherein the first biomarker binder is coupled with one or more first fluorophores,
wherein the second biomarker binder is coupled with one or more second fluorophores,
wherein the first biomarker binder binds or couples with a biomarker,
wherein the second biomarker binder binds or couples with the biomarker,
wherein the first biomarker binder or the second biomarker binder comprises (i) an amplifier that includes nucleotides or (ii) a chemical structure that is coupled with a metal and/or a dielectric material, wherein the amplifier is a linear amplifier or a nonlinear amplifier,
wherein the fluidic container further comprises a plurality of three-dimensional (3-D) structures,
wherein the three-dimensional (3-D) structures are spaced or arranged in a one-dimensional (1-D) array or in a two-dimensional (2-D) array,
wherein a pitch or a duty cycle of the one-dimensional (1-D) array or the two-dimensional (2-D) array of the three-dimensional (3-D) structures is varied for an enhancement of a fluorescence emission or a light signal,
wherein at least (i) one of the one or more first fluorophores or (ii) one of the one or more second fluorophores is within a geometrical area in a horizontal plane, wherein the geometrical area in the horizontal plane includes a center region or a middle region in the horizontal plane, wherein the center region or the middle region in the horizontal plane is within a gap in the horizontal plane, wherein the geometrical area in the horizontal plane is defined by at least the gap in the horizontal plane, wherein the gap in the horizontal plane is defined by at least one of the one or more three-dimensional (3-D) structures,
or wherein at least (i) one of the one or more first fluorophores or (ii) one of the one or more second fluorophores is coupled with a near field lens, wherein the near field lens comprises a metal thin-film,
wherein at least one of the three-dimensional (3-D) structures is coupled with an optical resonator,
(b) a light source or light sources for inducing the fluorescence emission or the light signal; and
(c) a device for detecting the fluorescence emission or the light signal, wherein the device comprises (i) a photodiode or (ii) a light sensor.

### Claim 67 (depends on 66)

The optical biomodule according to claim 66, wherein the fluidic container further comprises a substrate or a well or an optical waveguide.

### Claim 68 (depends on 66)

The optical biomodule according to claim 66, wherein at least one of the three-dimensional (3-D) structures is on a substrate or within a well or within an optical waveguide.

### Claim 69 (depends on 66)

The optical biomodule according to claim 66, wherein at least one of the three-dimensional (3-D) structures is further coupled with (i) a photonic crystal (PC) or (ii) a second metamaterial, wherein the second metamaterial is an Epsilon-Near-Zero (ENZ) or (iii) a third metamaterial, wherein the third metamaterial is a hyperbolic metamaterial (HMM).

### Claim 70 (depends on 66)

The optical biomodule according to claim 66, wherein at least one of the three-dimensional (3-D) structures is coupled or integrated with the light source, wherein the light source comprises a nanoscaled light source or quantum-entangled photons, wherein a maximum dimension of the nanoscaled light source is less than 1000 nanometers.

### Claim 71

An optical biomodule comprising:
(a) a fluidic container;
wherein the fluidic container comprises one or more (i) materials or (ii) first metamaterials,
wherein the fluidic container further comprises a first biomarker binder and/or a second biomarker binder,
wherein the first biomarker binder comprises one or more segments,
wherein the second biomarker binder comprises one or more segments,
wherein the first biomarker binder is coupled with one or more first fluorophores,
wherein the second biomarker binder is coupled with one or more second fluorophores,
wherein the first biomarker binder binds or couples with a biomarker,
wherein the second biomarker binder binds or couples with the biomarker,
wherein the first biomarker binder or the second biomarker binder comprises (i) an amplifier that includes nucleotides or (ii) a chemical structure that is coupled with a metal and/or a dielectric material, wherein the amplifier is a linear amplifier or a nonlinear amplifier,
wherein the fluidic container further comprises a plurality of three-dimensional (3-D) structures,
wherein the three-dimensional (3-D) structures are spaced or arranged in a one-dimensional (1-D) array or in a two-dimensional (2-D) array,
wherein a pitch or a duty cycle of the one-dimensional (1-D) array or the two-dimensional (2-D) array of the three-dimensional (3-D) structures is varied for an enhancement of a fluorescence emission or a light signal,
wherein at least (i) one of the one or more first fluorophores or (ii) one of the one or more second fluorophores is within a geometrical area in a horizontal plane, wherein the geometrical area in the horizontal plane includes a center region or a middle region in the horizontal plane, wherein the center region or the middle region in the horizontal plane is within a gap in the horizontal plane, wherein the geometrical area in the horizontal plane is defined by at least the gap in the horizontal plane, wherein the gap in the horizontal plane is defined by at least one of the one or more three-dimensional (3-D) structures,
or wherein at least (i) one of the one or more first fluorophores or (ii) one of the one or more second fluorophores is coupled with a near field lens, wherein the near field lens comprises a metal thin-film,
wherein at least one of the three-dimensional (3-D) structures is coupled with a photonic crystal (PC),
(b) a light source or light sources for inducing the fluorescence emission or the light signal; and
(c) a device for detecting the fluorescence emission or the light signal, wherein the device comprises (i) a photodiode or (ii) a light sensor.

### Claim 72 (depends on 71)

The optical biomodule according to claim 71, wherein the fluidic container further comprises a substrate or a well or an optical waveguide.

### Claim 73 (depends on 71)

The optical biomodule according to claim 71, wherein at least one of the three-dimensional (3-D) structures is on a substrate or within a well or within an optical waveguide.

### Claim 74 (depends on 71)

The optical biomodule according to claim 71, wherein at least one of the three-dimensional (3-D) structures is further coupled with (i) an optical resonator or (ii) a second metamaterial, wherein the second metamaterial is an Epsilon-Near-Zero (ENZ) or (iii) a third metamaterial, wherein the third metamaterial is a hyperbolic metamaterial (HMM).

### Claim 75 (depends on 71)

The optical biomodule according to claim 71, wherein at least one of the three-dimensional (3-D) structures is coupled or integrated with the light source, wherein the light source comprises a nanoscaled light source or quantum-entangled photons, wherein a maximum dimension of the nanoscaled light source is less than 1000 nanometers.
